← Issue №19/ week of Nov 8, 2026/Pancreas/Biliary

Safety of Continuing Single-Agent Antithrombotic Therapy During Emergency Cholecystectomy for Acute Cholecystitis: An Overlap-Weighted Propensity Score Analysis With the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary retrospective · n=1,018 · Nov 5, 2026 · J Hepatobil Pancreat Sci · IF 3.8

Safety of Continuing Single-Agent Antithrombotic Therapy During Emergency Cholecystectomy for Acute Cholecystitis: An Overlap-Weighted Propensity Score Analysis With the Hiroshima Surgical Study Group of Clinical Oncology (HiSCO).

New evidencecholedocholithiasisERCPbiliary stricture
Clinical takeawayWhen adequate antithrombotic washout is not feasible, these data support proceeding with emergency cholecystectomy for acute cholecystitis on single-agent therapy; the cohort was retrospective and the primary outcome was blood loss.
What it foundIntraoperative blood loss >100 mL occurred in 25.4% on continued single-agent antithrombotic therapy vs 27.3% without (RR 0.93, 95% CI 0.69-1.26), within the prespecified margin of 1.5; perioperative bleeding complications and stay did not differ.
ContextResults were consistent in sensitivity and drug-specific subgroup analyses, including direct oral anticoagulants (1,018 patients, seven institutions).
Emergingsuggested applicable standard· EASL (European Association for the Study of the Liver), "EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones," Journal of Hepatology 2016;65(1):146-181, 2016

… For acute cholecystitis, early laparoscopic cholecystectomy preferably within 72 h of admission should be performed by surgeons with adequate expertise (high quality; strong recommendation). …

From our summary of this standard, unedited — the part the paper bears on. … marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

Abdominal ultrasound should be performed in a patient with a recent history of biliary pain (high quality evidence; strong recommendation); in case of strong clinical suspicion of gallbladder stones and negative abdominal ultrasound, EUS (or magnetic resonance imaging) may be performed (low quality; weak). Cholecystectomy is the preferred treatment for symptomatic gallbladder stones (moderate quality; strong recommendation), and laparoscopic cholecystectomy is the standard method, including for acute calculous cholecystitis (high quality; strong), although mini-laparotomy cholecystectomy (laparotomy <8 cm) is an equally acceptable alternative (high quality; strong). For uncomplicated biliary colic, cholecystectomy should be performed as early as possible (low quality; weak recommendation); EASL qualifies that cholecystectomy may not be necessary if biliary colic has not occurred within the last 5 years or after just one episode of colic (~50% chance of another colic within 1 year). For acute cholecystitis, early laparoscopic cholecystectomy preferably within 72 h of admission should be performed by surgeons with adequate expertise (high quality; strong recommendation). Antibiotics are NOT recommended at all times in mild acute cholecystitis, i.e. without cholangitis, bacteremia/sepsis, abscess or perforation (very low quality; weak recommendation). Biliary colic should be treated with NSAIDs, e.g. diclofenac 50-75 mg IM, ketoprofen 200 mg IV, or indomethacin 50 mg IV / 2 × 75 mg suppositories (moderate quality; weak), with spasmolytics and, for severe symptoms, opioids such as buprenorphine (low quality; strong). In severe acute cholecystitis or difficult biliary anatomy, subtotal cholecystectomy (laparoscopic or open) or percutaneous cholecystostomy followed by later cholecystectomy are options; percutaneous cholecystostomy is a treatment alternative in high-risk patients, but whether definitive cholecystectomy is still needed afterwards is explicitly unsolved (no RCTs) and cholecystectomy should be considered, since patients who improve after cholecystostomy may worsen during follow-up. In the elderly and those with high anaesthetic risk, cholecystectomy should be performed for gallstone complications (acute cholecystitis, gallstone pancreatitis, obstructive jaundice) as soon as general status allows (low quality; weak), and laparoscopic cholecystectomy should not be withheld on the basis of chronological age alone (very low quality; weak). Routine treatment is NOT recommended for asymptomatic gallbladder stones (very low quality; weak recommendation). Oral bile-acid litholysis, alone or with ESWL, is not recommended (moderate quality; strong). In patients with simultaneous gallbladder and bile duct stones, early laparoscopic cholecystectomy should be performed within 72 h after preoperative ERCP for choledocholithiasis (moderate quality; strong); same-day but separate ERCP and cholecystectomy are not recommended. Before elective cholecystectomy, abdominal ultrasound confirming stones is required (moderate quality; strong) and no other routine tests are necessary; liver biochemical tests in individually selected cases (very low quality; weak). Routine intraoperative cholangiography is not supported by current evidence.

EASL (European Association for the Study of the Liver), "EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones," Journal of Hepatology 2016;65(1):146-181, 2016 · reviewed 2026-07-23 ↗
Tadokoro T … Hiroshima Surgical Study Group of Clinical Oncology (HiSCO) · Journal of Hepato-Biliary-Pancreatic Sciences · IF 3.8 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues